Table 1 Baseline characteristics of participants by LDL-C/Non-HDL-C concordance/discordance

N

79

38

43

242

Age, year

65.1 ± 12.8

64.0 ± 15.1

65.6 ± 12.1

66.6 ± 12.9

0.596

Male, n (%)

52 (65.8)

22 (57.9)

28 (65.1)

137 (56.6)

0.432

Smoking, n (%)

32 (40.5)

14 (36.8)

17 (39.5)

97 (40.1)

0.983

Drinking, n (%)

27 (34.2)

9 (23.7)

14 (32.6)

53 (21.9)

0.114

Hypertension, n (%)

62 (78.5)

25 (65.8)

34 (79.1)

191 (78.9)

0.336

DM, n (%)

30 (38.0)

14 (36.8)

15 (34.9)

99 (40.9)

0.857

SBP, mmHg

122.7 ± 16.5

125.1 ± 16.4

124.8 ± 15.1

134.3 ± 17.8

0.000

DBP, mmHg

72.8 ± 10.9

72.1 ± 7.3

72.2 ± 8.1

76.6 ± 10.1

0.001

BMI, kg/m²

25.0 ± 3.2

25.6 ± 3.6

26.0 ± 2.7

25.7 ± 3.5

0.312

FBG, mmol/L

5.8 ± 2.3

5.9 ± 1.9

5.5 ± 1.5

6.0 ± 2.4

0.464

HDL-C, mmol/L

1.22 ± 0.35

1.09 ± 0.30

1.19 ± 0.31

1.17 ± 0.30

0.164

LDL-C, mmol/L

1.52 ± 0.22

1.58 ± 0.25

2.25 ± 0.63

2.85 ± 0.64

0.000^*

Non-HDL-C, mmol/L

1.89 ± 0.34

3.50 ± 0.79

2.27 ± 0.49

3.51 ± 0.70

0.000^#

TC, mmol/L

3.12 ± 0.47

4.59 ± 0.82

3.46 ± 0.58

4.68 ± 0.71

0.000

TG, mmol/L

1.34 ± 1.03

2.11 ± 2.18

1.19 ± 0.47

2.08 ± 1.56

0.000

apoB, mmol/L

0.58 ± 0.10

0.94 ± 0.15

0.71 ± 0.10

0.94 ± 0.16

0.000^#

UA, μmol/L

324.8 ± 76.2

354.7 ± 76.5

350.3 ± 89.2

355.2 ± 89.6

0.055

homocysteine, mmol/L

14.4 ± 7.0

14.2 ± 9.2

14.0 ± 5.0

15.0 ± 8.1

0.812

eGFR, mL/(min·1.73 m²)

93.3 ± 16.3

94.5 ± 15.5

92.0 ± 14.7

89.6 ± 17.7

0.184

HGB, g/L

136.3 ± 14.7

135.1 ± 14.6

134.7 ± 13.3

136.7 ± 16.4

0.847

HR, bpm

67.6 ± 10.2

68.8 ± 9.2

65.4 ± 9.6

68.9 ± 9.5

0.148

Lipid-lowering therapy, n (%)

52 (65.8)

19 (50.0)

28 (65.1)

81 (33.5)

0.000

baPWV, cm/s

1533.0 ± 330.9

1713.3 ± 604.8

1605.4 ± 221.4

1790.7 ± 393.8

0.000